Indian Army Department of Military Affairs Medical Supplies Tender 2025: Recombinant Erythropoietin, Ophthalmic & Topical Drugs
Indian Army
HYDERABAD, TELANGANA
Bid Publish Date
09-Sep-2025, 9:46 am
Bid End Date
30-Sep-2025, 10:00 am
Location
Progress
RAQuantity
94867
Category
ACYCLOVIR 250MG INJ
Bid Type
Two Packet Bid
A tender has been published for Indian Army ACYCLOVIR 250MG INJ, AMIODARONE HCL 150MG 3ML INJ, ANTIPHLEBITIS LIQUID CONTAINING UNFRACTIONATED HEPARIN 1000 U PER ML, CEFEPIME IGM INJ, CLINDAMYCIN 600MG INJ, ENOXAPARIN 40MG PER 0 POINT 4ML INJ, INJ ACETYL CYSTEINE 20 PERCENT 400MG PER 2ML AMPULE, INJ AZITHROMYCIN 500MG, INJ CEFTAZIDIME PLUS AVIBACTUM 2GM PER 0 POINT 5GM, INJ COLISTHIMETHATE 2MU, INJ ELORES CEFTRAXONE PLUS SULBACTUM, INJ LEVERACITAM 100 MG PER 5ML VIAL, INJ LIGNOCAINE HYDROCHLORIDE 4 PERCENT TOPICAL SOLN BOTTLE OF 30ML, INJ LORAZEPAM 1MG PER ML, INJ MEROPENEM 2GM VIAL, INJ METHYLCOBALAMINE 1000MG, INJ NITROGLYCERINE OR GLYCERYL TRINITRATE 5MG, INJ PHENYTOIN SODIUM 100MG PER 2ML, INJ THIAMINE 100MG PER ML 2ML AMP, LABETALOL HCL 5MG PER ML 4ML INJ, MAGNESIUM SULPHATE 50PERCENT WV INJ, MESNA 200MG INJ, METOCLOPRAMIDE HCL 5MG PER ML 2ML INJ, N ACETYL CYSTEINE 200MG PER ML 5ML AMPOULE, NEOSTIGMINE 0 POINT 5MG 1ML INJ, SODIUM VALPORATE 100MG PER ML INJ, INJ DOXYCYCLINE 100MG, VASOPRESSIN 20UNITS PER ML INJ 1 ML AMPOULE, VECURONIUM BROMIDE 4MG PER ML 1ML INJ in WEST DELHI, DELHI. Quantity: 94867 by. Submission Deadline: 30-09-2025 10: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
HYDERABAD, TELANGANA
Indian Army
RAJAURI, JAMMU & KASHMIR
Indian Army
HYDERABAD, TELANGANA
Indian Air Force
JALPAIGURI, WEST BENGAL
Dg Armed Forces Medical Service
GURDASPUR, PUNJAB
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | ACYCLOVIR 250MG INJ | Description1 | 2,025 | amp or vial | dglp@2023 | 15 |
| 1 | AMIODARONE HCL 150MG 3ML INJ | Description1 | 800 | amp | dglp@2023 | 15 |
| 1 | ANTIPHLEBITIS LIQUID CONTAINING UNFRACTIONATED HEPARIN 1000 U PER ML | Description1 | 465 | vial | dglp@2023 | 15 |
| 1 | CEFEPIME IGM INJ | Description1 | 1,700 | vial | dglp@2023 | 15 |
| 1 | CLINDAMYCIN 600MG INJ | Description1 | 7,290 | vial | dglp@2023 | 15 |
| 1 | ENOXAPARIN 40MG PER 0 POINT 4ML INJ | Description1 | 4,292 | pfs | dglp@2023 | 15 |
| 1 | INJ ACETYL CYSTEINE 20 PERCENT 400MG PER 2ML AMPULE | Description1 | 1,113 | no | dglp@2023 | 15 |
| 1 | INJ AZITHROMYCIN 500MG | Description1 | 3,876 | vial | dglp@2023 | 15 |
| 1 | INJ CEFTAZIDIME PLUS AVIBACTUM 2GM PER 0 POINT 5GM | Description1 | 627 | vial | dglp@2023 | 15 |
| 1 | INJ COLISTHIMETHATE 2MU | Description1 | 903 | vial | dglp@2023 | 15 |
| 1 | INJ ELORES CEFTRAXONE PLUS SULBACTUM | Description1 | 906 | vial | dglp@2023 | 15 |
| 1 | INJ LEVERACITAM 100 MG PER 5ML VIAL | Description1 | 4,276 | vial | dglp@2023 | 15 |
| 1 | INJ LIGNOCAINE HYDROCHLORIDE 4 PERCENT TOPICAL SOLN BOTTLE OF 30ML | Description1 | 1,725 | bottle | dglp@2023 | 15 |
| 1 | INJ LORAZEPAM 1MG PER ML | Description1 | 1,383 | amp | dglp@2023 | 15 |
| 1 | INJ MEROPENEM 2GM VIAL | Description1 | 3,450 | no | dglp@2023 | 15 |
| 1 | INJ METHYLCOBALAMINE 1000MG | Description1 | 4,080 | amp | dglp@2023 | 15 |
| 1 | INJ NITROGLYCERINE OR GLYCERYL TRINITRATE 5MG | Description1 | 3,624 | amp | dglp@2023 | 15 |
| 1 | INJ PHENYTOIN SODIUM 100MG PER 2ML | Description1 | 9,735 | amp | dglp@2023 | 15 |
| 1 | INJ THIAMINE 100MG PER ML 2ML AMP | Description1 | 8,920 | amp | dglp@2023 | 15 |
| 1 | LABETALOL HCL 5MG PER ML 4ML INJ | Description1 | 3,540 | amp or vial | dglp@2023 | 15 |
| 1 | MAGNESIUM SULPHATE 50PERCENT WV INJ | Description1 | 4,100 | amp or vial | dglp@2023 | 15 |
| 1 | MESNA 200MG INJ | Description1 | 2,274 | amp | dglp@2023 | 15 |
| 1 | METOCLOPRAMIDE HCL 5MG PER ML 2ML INJ | Description1 | 7,953 | amp or vial | dglp@2023 | 15 |
| 1 | N ACETYL CYSTEINE 200MG PER ML 5ML AMPOULE | Description1 | 3,480 | amp | dglp@2023 | 15 |
| 1 | NEOSTIGMINE 0 POINT 5MG 1ML INJ | Description1 | 2,221 | amp or vial | dglp@2023 | 15 |
| 1 | SODIUM VALPORATE 100MG PER ML INJ | Description1 | 2,415 | amp or vial | dglp@2023 | 15 |
| 1 | INJ DOXYCYCLINE 100MG | Description1 | 4,140 | amp | dglp@2023 | 15 |
| 1 | VASOPRESSIN 20UNITS PER ML INJ 1 ML AMPOULE | Description1 | 1,256 | amp | dglp@2023 | 15 |
| 1 | VECURONIUM BROMIDE 4MG PER ML 1ML INJ | Description1 | 2,298 | amp or vial | dglp@2023 | 15 |
Discover companies most likely to bid on this tender
Past Performance
Bidder Turnover
OEM Authorization Certificate
Additional Doc 2 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
17-Dec-2025, 11:00 am
End
18-Dec-2025, 12:00 pm
Duration: 25 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS